Possible mechanisms hypothesized by researchers: Indirect effects: Rapid weight loss, hormonal changes, or shifts in testosterone levels can affect erections
Conclusion The evidence supports a nuanced conclusion regarding GLP-1 agonists for obesity in non-diabetic patients: they represent a significant therapeutic advance with game-changing potential currently limited by practical implementation challenges
Three receptor pathways means three separate adaptation processes happening simultaneously, and rushing any one of them creates problems
Isaacs: We have the AiDAPT study, which was a randomized controlled trial with a hybrid closed-loop pump compared with standard therapy
Core components that define differentiation, like adherence engines, behavioral reinforcement models, and data-driven retention systems, are almost always worth building, even if it means a higher upfront investment
Meet our medical team at the Aptos clinic or by secure video call